A multi-centre study on the long-term benefits of tinnitus management using Neuromonics Tinnitus Treatment.
The Neuromonics Tinnitus Treatment is based on individually customized acoustic stimulation and structured counseling. To assess the long-term clinical outcomes of the Neuromonics Tinnitus Treatment, specifically, to determine whether benefits achieved at the conclusion of the prescribed treatment program were retained over the longer term. This study involved 70 subjects who had previously undergone the treatment across six clinics located in Australia and United States. Patients had concluded the treatment at least six, and up to 36 months, before the commencement of this study. The Tinnitus Reaction Questionnaire was used to assess tinnitus distress, and patients were asked to report on percentage of time of awareness of and disturbance by their tinnitus. Long-term data were compared to data reported throughout the course of the treatment. Patients achieved statistically significant improvement of their tinnitus distress. The success rate (at least 40% reduction in TRQ score) for this cohort of patients was 75.7% at the conclusion of the program and the majority of patients sustained the benefits in the long-term. Results revealed that NTT provides a consistent and stable relief of tinnitus distress.